NFE2L2 and pancreatic adenocarcinoma: Analyzing data publicly available in KMplot [56], both NFE2L2 and HMOX1 expression are significantly (p = 4.16 × 10−48 and p = 7.81 × 10−54, respectively) upregulated in pancreatic adenocarcinomas compared with non-cancerous pancreatic tissue (Figure 1A).